Long-term follow-up shows epcoritamab drives deep, durable responses in relapsed/refractory follicular lymphoma (R/R FL)

被引：0

作者：

Izutsu, K. ^{[1
]}

Akahane, D. ^{[2
]}

Toubai, T. ^{[3
]}

Saito, T. ^{[4
]}

Mishima, Y. ^{[5
]}

Fujisaki, T. ^{[6
]}

Kitawaki, T. ^{[7
]}

Kumode, T. ^{[8
]}

Suehiro, Y. ^{[9
]}

Ishitsuka, K. ^{[10
]}

Conlon, R. ^{[11
]}

Noguchi, H. ^{[12
]}

Buchbjerg, J. ^{[13
]}

Favaro, E. ^{[13
]}

Fukuhara, N. ^{[14
]}

机构：

[1] Natl Canc Ctr, Dept Hematol, Tokyo, Japan

[2] Tokyo Med Univ, Dept Hematol, Tokyo, Japan

[3] Yamagata Univ, Div Hematol & Cell Therapy, Fac Med, Yamagata, Japan

[4] Aichi Canc Ctr Hosp, Dept Hematol & Cell Therapy, Nagoya, Aichi, Japan

[5] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Hematol Oncol, Tokyo, Japan

[6] Matsuyama Red Cross Hosp, Japan Red Cross Soc, Dept Hematol, Matsuyama, Ehime, Japan

[7] Kyoto Univ Hosp, Dept Hematol & Oncol, Kyoto, Japan

[8] Kindai Univ, Dept Hematol & Rheumatol, Osaka, Japan

[9] Natl Hosp Org Kyushu Canc Ctr, Dept Hematol & Cell Therapy, Fukuoka, Japan

[10] Kagoshima Univ Hosp, Dept Hematol & Rheumatol, Kagoshima, Japan

[11] AbbVie, N Chicago, IL USA

[12] Genmab KK, Tokyo, Japan

[13] Genmab AS, Copenhagen, Denmark

[14] Tohoku Univ, Dept Hematol, Sendai, Miyagi, Japan

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.07.548

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MO20-2

引用

页码：S1337 / S1337

页数：1

共 50 条

[1] Long-term follow-up of patients (pts) with relapsed or refractory (r/r) follicular lymphoma (FL) treated with copanlisib.
Leppa, Sirpa
Santoro, Armando
Demeter, Judit
Follows, George
Lenz, Georg
Kim, Won Seog
Mollica, Luigina
Nagler, Arnon
Diong, Colin Phipps
Provencio, Mariano
Stevens, Don A.
Trevarthen, David R.
Wang, MingLu
Wirtz, Oliver
Miriyala, Ashok
Vargas, Jose Garcia
Childs, Barrett H.
Zinzani, Pier Luigi
Dreyling, Martin H.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[2] Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis
Noy, Ariela
de Vos, Sven
Coleman, Morton
Martin, Peter
Flowers, Christopher R.
Thieblemont, Catherine
Morschhauser, Franck
Collins, Graham P.
Shuo, Ma
Peles, Shachar
Smith, Stephen D.
Barrientos, Jacqueline C.
Chong, Elizabeth
Wu, Shiquan
Cheung, Leo W-K
Kwei, Kevin
Hauns, Bernhard
Arango-Hisijara, Israel
Chen, Robert
BLOOD ADVANCES, 2020, 4 (22) : 5773 - 5784
[3] CURRENT EPCORITAMAB PLUS RITUXIMAB AND LENALIDOMIDE (R2) PERCEPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)
Levine, E.
Gentile, D.
Swain, R.
Bone, R. N.
Jennings-Zhang, L.
Jeune-Smith, Y.
Feinberg, B.
VALUE IN HEALTH, 2024, 27 (12) : S342 - S342
[4] Understanding the patient experience in follicular lymphoma (FL), relapsed/refractory FL (R/R FL), and relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL)
Bell, Jill A.
Cherepanov, Dasha
Revicki, Dennis
Speck, Rebecca M.
Swett, Laura
Stumpo, Kate
Rong, Yuanxin
Gordon, Leo I.
QUALITY OF LIFE RESEARCH, 2019, 28 : S67 - S68
[5] Durable Long-Term Remission with Allogeneic Hematopoietic Cell Transplantation (Ha) for Relapsed/Refractory Follicular Lymphoma (FL)
Jagadeesh, Deepa
Rybicki, Lisa
Abounader, Donna
Dean, Robert M.
Hill, Brian
Liu, Hien
Sobecks, Ronald M.
Hamilton, Betty Ky
Gerds, Aaron
Ferraro, Christina
Starn, Jamie
Winslow, Victoria
Pohlman, Brad
Kalaycio, Matt E.
Bolwell, Brian
Majhail, Navneet S.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S223 - S224
[6] Clinical Outcomes of Patients With Relapsed/Refractory Follicular Lymphoma (R/R FL) Treated With Tisagenlecleucel: Phase 2 ELARA 3-Year Follow-Up
Schuster, Stephen J.
Fowler, Nathan Hale
Dickinson, Michael
Martinez-Lopez, Joaquin
Kolstad, Arne
Butler, Jason
Ghosh, Monalisa
Popplewell, Leslie
Chavez, Julio C.
Bachy, Emmanuel
Kato, Koji
Harigae, Hideo
Kersten, Marie Jose
Andreadis, Charalambos
Riedell, Peter A.
Ho, P. Joy
Perez-Simon, Jose Antonio
Chen, Andy I.
Nastoupil, Loretta J.
von Tresckow, Bastian
Ferreri, Andres Jose Maria
Teshima, Takanori
Patten, Piers E. M.
McGuirk, Joseph P.
Petzer, Andreas L.
Offner, Fritz
Viardot, Andreas
Zinzani, Pier Luigi
Malladi, Ram
Zia, Aiesha
Awasthi, Rakesh
Paule, Ines
Germano, Davide
Ramos, Roberto
Hsu, Pei
Thieblemont, Catherine
Dreyling, Martin
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S495 - S496
[7] Extended Follow-Up Beyond 2.5 Years Demonstrates Long-Term Efficacy in Complete Responders Following Epcoritamab Monotherapy in Relapsed or Refractory Large B-Cell Lymphoma (R/R LBCL)
Karimi, Yasmin H.
Thieblemont, Catherine
Ghesquieres, Herve
Cheah, Chan Y.
Clausen, Michael Roost
Cunningham, David
Jurczak, Wojciech
Linton, Kim M.
Hutchings, Martin
Phillips, Tycel
Farooq, Umar
Kim, Won Seog
Dinh, Minh H.
Ghosh, Jagannath
Pallai, Rajash
Wielgos-Bonvallet, Monica
Eskelund, Christian
Lugtenburg, Pieternella J.
Vose, Julie M.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S461 - S462
[8] ELARA Trial Update: Long-Term Clinical Outcomes and Correlative Efficacy Analyses of Tisagenlecleucel in Patients With Relapsed/Refractory Follicular Lymphoma (R/R FL)
Fowler, Nathan
Dreyling, Martin
Dickinson, Michael
Martinez-Lopez, Joaquin
Kolstad, Arne
Butler, Jason
Ghosh, Monalisa
Popplewell, Leslie
Chavez, Julio
Bachy, Emmanuel
Kato, Koji
Harigae, Hideo
Kersten, Marie Jose
Andreadis, Charalambos
Riedell, Peter
Ho, P. Joy
Antonio Perez-Simon, Jose
Chen, Andy
Nastoupil, Loretta
von Tresckow, Bastian
Ferreri, Andres Jose Maria
Teshima, Takanori
Patten, Piers
McGuirk, Joseph
Petzer, Andreas
Offner, Fritz
Viardot, Andreas
Zinzani, Pier
Malladi, Ram
Paule, Ines
Zia, Aiesha
Awasthi, Rakesh
Han, Xia
Germano, Davide
O'Donovan, Darragh
Ramos, Roberto
Masood, Aisha
Thieblemont, Catherine
Schuster, Stephen
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S534 - S535
[9] Long-Term Follow-up and Analysis of Dose Groups with Ibrutinib in Relapsed Follicular Lymphoma
Fowler, Nathan
Boyd, Thomas E.
Sharman, Jeff P.
Smith, Sonali M.
Clow, Fong
Chu, Alvina D.
Advani, Ranjana H.
BLOOD, 2015, 126 (23)
[10] Long-term follow-up of patients undergoing allogeneic hematopoietic stem cell transplantation for relapsed or refractory follicular lymphoma
Hashida, Risa
Kato, Jun
Okamoto, Shinichiro
Mori, Takehiko
BONE MARROW TRANSPLANTATION, 2018, 53 : 280 - 281

← 1 2 3 4 5 →